medigraphic.com
ISSN 0210-5187 (Electronic)

2019, Number 1

<< Back Next >>

Med Cutan Iber Lat Am 2019; 47 (1)

Treatment of early stages of mycosis fungoides with narrow band UVB the mycosis fungoides in early stage

Reyes V, Bosio BM, Ruiz LA, Kurpis M

Language: Spanish
References: 20
Page: 29-33
PDF size: 224.23 Kb.


ABSTRACT

Treatment of early stages of mycosis fungoides with UVB narrow band. Mycosis fungoides early stage has been treated with various agents: topical steroids, nitrogen mustard, PUVA, radiotherapy, among others. However, these treatments they are associated with side effects. Narrow band UVB (UVB-ba) has a similar therapeutic effect, but with a greater security profile. The aim was to determine the response to UVB-ba patients with MF stage IA, IB, in the Service of Dermatology of the Private Hospital (from May 2009 to December of 2014). Correlating the total energy dose and the number of sessions with the response reached. Describe the reactions adverse events and the demographic characteristics of the population. He conducted a prospective, descriptive, analytical, observational study. The cumulative dose and the number of sessions were calculated end of treatment. A total of 20 patients began with UVB-ba from May 2009 to December 2014: 8 women and 12 men. Average age: 55 years, phototype: more frequent two (71%). Average sick time: three years (one month and 11 years). 55% were in stage IA, 45% IB. Complete response reached in 60% (12 patients), 30% partial (six patients), 10% without response (two patients). The average time of remission: 17.44 months. UVB-ba is a safe and effective treatment for patients with MF in early stage with a remission period of more than one year.


REFERENCES

  1. Clark C, Dawe RS, Evans AT, LoweG, Ferguson J. Narrowband TL-01 phototherapy for patch-stage mycosis fungoides. Archives of Dermatology. 2000; 136 (6): 748-752.

  2. Kural Y, Onsun N, Aygin S, Demirkesen C, Büyükbabani N. Efficacy of narrowband UVB phototherapy in early stage of mycosis fungoides. Journal of the European Academy of Dermatology and Venereology. 2006; 20 (1): 103-104.

  3. Pavlotsky F, Barzilai A, Kasem R, Shpiro D, Trau H. UVB in the management of early stage mycosis fungoides. Journal of the European Academy of Dermatology and Venereology. 2006; 20 (5): 565-572.

  4. Duncan K, Heald P. Cutaneous T-cell lymphoma: centuries of controversy. Semin Cutan Med Surg. 1998; 17 (2): 133-1340.

  5. Brazzelli V, Antoninetti M, Palazzini S, Prestinari F, Borroni G. Narrow band ultraviolet therapy in early stage mycosis fungoides: study on 20 patients. Photodermatology, Photoimmunology & Photomedicine. 2007; 23 (6): 229-233.

  6. National Comprehensive Cancer Network (NCCN). Clinical practice guidelines in oncology. Mycosis fungoides/Sézary syndrome. NCCN Version 4. 2014.

  7. Coronel-Pérez IM, Carrizosa-Esquivel AM, Camacho-Martínez F. Narrow band UVB therapy in early stage mycosis fungoides. A study of 23 patients. Actas Dermo-Sifiliográficas. 2007; 98 (4): 259-264.

  8. Trautinger F. Phototherapy of mycosis fungoides. Photodermatology, Photoimmunology & Photomedicine. 2011; 27 (2): 68-74.

  9. El Mofty M, El Darouty M, Salonas M, Bosseila M, Sobeih S, Leheta T et al. Narrow band UVB (311 nm), psoralen UVB (311 nm) and PUVA therapy in the treatment of early stage mycosis fungoides: a right-left comparative study. Photodermatology, Photoimmunology & Photomedicine. 2005; 21 (6): 281-286.

  10. Xiao T, Xia LX, Yang ZH, He CD, Gao XH, Chen HD. Narrow-band ultraviolet B phototherapy for early stage mycosis fungoides. European Journal of Dermatology. 2008; 18 (6): 660-662.

  11. Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW. Narrowband UVB phototherapy for early-stage mycosis fungoides. Journal of the American Academy of Dermatology. 2002; 47 (2): 191-197.

  12. Ghodsi SZ, Hallaji Z, Balighi K, Safar F, Chams-Davatchi C. Narrow band UVB in the treatment of early stage mycosis fungoides: report of 16 patients. Clinical and Experimental Dermatology. 2005; 30 (4): 376-378.

  13. Duthie MS, Kimber I, Norval M. The effects of ultraviolet radiation on the human immune system. British Journal of Dermatology. 1999; 140: 995-1009.

  14. Diederen PV, van Weelden H, Sanders CJ, Toonstra J, van Vloten WA. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study. Journal of the American Academy of Dermatology. 2003; 48 (2): 215-219.

  15. Zurita G, Garcés J, Flores M, Uraga E. Terapia ultravioleta en estadios tempranos de micosis fungoide ¿UVB Banda angosta o PUVA? Act Terap Dermatol. 2006; 29: 16-20.

  16. Vicuña-Ríos CM, Sánchez-Félix G, Paredes-Arcos AA. Respuesta de las dermatosis tratadas con fototerapia UVB de banda angosta en el Hospital Nacional Edgardo Rebagliati Martins 2002-2005. Dermatol Perú. 2007; 17 (2): 100-109.

  17. Domínguez MA, González SE. Tratamiento de las dermatosis más frecuentes con radiación ultravioleta de tipo B en el Centro Dermatológico de Pascua. Rev Cent Dermatol de Pascua. 2008; 17: 6-10.

  18. Boztepe G, Sahin S, Ayhan M, Erkin G, Kolemen F. Narrowband ultraviolet B phototherapy to clear and maintain clearance in patients with mycosis fungoides. Journal of the American Academy of Dermatology. 2005; 53 (2): 242-246.

  19. Coven TR, Burack LH, Gilleaudeau P, Keogh M, Ozawa M, Krueger JG. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B2. Archives of Dermatology. 1997; 133 (12): 1514-1522.

  20. Gökdemir G, Barutcuolu B, Sakz D, Kölü A. Narrowband UVB phototherapy for early stage mycosis fungoides: evaluation of clinical and histopathological changes. Journal of the European Academy of Dermatology and Venereology. 2006; 20 (7): 804-809.




2020     |     www.medigraphic.com